Prostaglandin D 2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma
Christina Gress,Maximilian Fuchs,Saskia Carstensen-Aurèche,Meike Müller,Jens M. Hohlfeld
DOI: https://doi.org/10.1371/journal.pone.0307750
IF: 3.7
2024-07-26
PLoS ONE
Abstract:Increased production of Prostaglandin D 2 (PGD 2 ) is linked to development and progression of asthma and allergy. PGD 2 is rapidly degraded to its metabolites, which initiate type 2 innate lymphoid cells (ILC2) migration and IL-5/IL-13 cytokine secretion in a PGD 2 receptor 2 (DP 2 )-dependent manner. Blockade of DP 2 has shown therapeutic benefit in subsets of asthma patients. Cellular mechanisms of ILC2 activity in response to PGD 2 and its metabolites are still unclear. We hypothesized that ILC2 respond non-uniformly to PGD 2 metabolites. ILC2s were isolated from peripheral blood of patients with atopic asthma. ILC2s were stimulated with PGD 2 and four PGD 2 metabolites (Δ 12 -PGJ 2 , Δ 12 -PGD 2 , 15-deoxyΔ 12,14 -PGD 2 , 9α,11β-PGF 2 ) with or without the selective DP 2 antagonist fevipiprant. Total RNA was sequenced, and differentially expressed genes (DEG) were identified by DeSeq2. Differential gene expression analysis revealed an upregulation of pro-inflammatory DEGs in ILC2s stimulated with PGD 2 (14 DEGs), Δ 12 -PGD 2 (27 DEGs), 15-deoxyΔ 12,14 -PGD 2 (56 DEGs) and Δ 12 -PGJ 2 (136 DEGs), but not with 9α,11β-PGF 2 . Common upregulated DEGs were i.e. ARG2, SLC43A2, LAYN, IGFLR1, or EPHX2. Inhibition of DP 2 via fevipiprant mainly resulted in downregulation of pro-inflammatory genes such as DUSP4, SPRED2, DUSP6, ETV1, ASB2, CD38, ADGRG1, DDIT4, TRPM2, or CD69. DEGs were related to migration and various immune response-relevant pathways such as " chemokine (C-C motif) ligand 4 production ", " cell migration" , "interleukin-13 production" , "regulation of receptor signaling pathway via JAK-STAT" , or "lymphocyte apoptotic process" , underlining the pro-inflammatory effects of PGD 2 metabolite-induced immune responses in ILC2s as well as the anti-inflammatory effects of DP 2 inhibition via fevipiprant. Furthermore, PGD 2 and metabolites showed distinct profiles in ILC2 activation. Overall, these results expand our understanding of DP 2 initiated ILC2 activity.
multidisciplinary sciences